Evidence map›Paper›PMID 31133847›Full record

ArticleFrontiers in pharmacology2019

Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study.

Karin Meissner, Nicola Talsky, Elisabeth Olliges, Carmen Jacob, Oliver J Stötzer, Christoph Salat, Michael Braun, Raluca Flondor

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karin MeissnerInstitute of Medical Psychology, Faculty of Medicine, LMU Munich, Munich, Germany.
Nicola TalskyInstitute of Medical Psychology, Faculty of Medicine, LMU Munich, Munich, Germany.
Elisabeth OlligesInstitute of Medical Psychology, Faculty of Medicine, LMU Munich, Munich, Germany.
Carmen JacobInstitute of Medical Psychology, Faculty of Medicine, LMU Munich, Munich, Germany.
Oliver J StötzerHaematology and Oncology, Outpatient Cancer Care Center, Munich, Germany.
Christoph SalatHaematology and Oncology, Outpatient Cancer Care Center, Munich, Germany.
Michael BraunBreast Center, Department of Gynecology, Red Cross Hospital, Munich, Germany.
Raluca FlondorInstitute of Medical Psychology, Faculty of Medicine, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe expectation of developing side effects can enhance the likelihood to develop them - a phenomenon referred to as nocebo effect. Whether nocebo effects can be reduced by lowering negative expectancies, is not clear. The aim of this prospective study was to learn more about the factors contributing to nausea expectancy and their potential role in actual occurrence of nausea in patients undergoing chemotherapy for the first time in their life.

methodsPatients scheduled for moderately emetogenic chemotherapeutic regimens filled in questionnaires to assess state anxiety and quality of life and to rate the expectancy of nausea as a side effect of chemotherapy. Patient diaries were used to monitor the severity of post-chemotherapy nausea in the 4 days following chemotherapy administration. Bivariate analyses complemented by multiple regression analyses were performed to identify the relationship between nausea expectation and nausea occurrence.

results121 female patients (mean age 53 years) with completed questionnaires were included in the analyses. The majority of the patients had a diagnosis of breast cancer (86%). The two main sources for nausea expectancy were positive history of nausea in other situations and state anxiety. Patients with high expectancy levels (first quartile) experienced greater nausea than those with lower expectancy levels. Bivariate analyses revealed a weak but non-significant association between nausea expectation and post-chemotherapy nausea. When controlling for age, type of cancer, history of nausea, state and trait anxiety, and global quality of life, positive history of nausea (

conclusionIn this female cohort, younger patients with lower initial quality of life and a positive history of nausea were at higher risk to develop nausea after first time chemotherapy. These patients may benefit from psychological co-interventions that aim to enhance quality of life.

Indexed as

cancerchemotherapyCINVexpectationnauseanocebo effectquality of life

Identifiers

PMID31133847
PMCPMC6524707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.